The potential of micron-sized amorphous mesoporous silica particles as a novel controlled
release drug delivery system for pulmonary administration has been investigated …

A highly versatile nanoplatform that couples mesoporous silica nanoparticles (MSNs) with
an aerosol technology to achieve direct nanoscale delivery to the respiratory tract is …

The aim of this study was to investigate the application of a spray-drying process for the
production of nanoporous microparticles (NPMPs) to budesonide, and to characterise the …

Diseases in the respiratory tract rank among the leading causes of death in the world, and
thus novel and optimized treatments are needed. The lungs offer a large surface for drug …

Inhalation therapy treating severe infectious disease is among the more complex and
emerging topics in controlled drug release. Micron-sized carriers are needed to deposit …

The goal of this research is preparation, optimization and in-vitro evaluation of rifampin-
loaded silica nanoparticles in order to use in the pulmonary drug delivery. Nanoparticles are …

The effect of suspension stabilizers, internal aqueous phase volume and polymer amount
were investigated for the production of protein loaded poly (d, l lactide-co-glycolide)(PLGA) …

A series of customized inhalable mono-dispersed poly-L-lactide microspheres (PLA-MS)
having hierarchical pore structures with either open or closed porosity were synthesized by …

Abstract Purpose. Relatively large (> 5 µm) and porous (mass density< 0.4 g/cm 3) particles
present advantages for the delivery of drugs to the lungs, eg, excellent aerosolization …

A solid lipid microparticle system containing budesonide was prepared by oil in water
emulsification followed by spray drying. The solid lipid system was studied in terms of …